Cardiovascular Systems (NASDAQ:CSII) and Encision (OTCMKTS:ECIA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability and valuation.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Cardiovascular Systems and Encision, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cardiovascular Systems 0 0 8 0 3.00
Encision 0 0 0 0 N/A

Cardiovascular Systems presently has a consensus target price of $46.75, suggesting a potential upside of 33.92%. Given Cardiovascular Systems’ higher probable upside, equities analysts clearly believe Cardiovascular Systems is more favorable than Encision.

Volatility & Risk

Cardiovascular Systems has a beta of 1.33, suggesting that its share price is 33% more volatile than the S&P 500. Comparatively, Encision has a beta of -0.27, suggesting that its share price is 127% less volatile than the S&P 500.


This table compares Cardiovascular Systems and Encision’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cardiovascular Systems -11.51% -15.62% -10.89%
Encision -2.19% -7.09% -3.37%

Valuation and Earnings

This table compares Cardiovascular Systems and Encision’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cardiovascular Systems $236.54 million 5.85 -$27.24 million ($0.79) -44.19
Encision $7.67 million 0.78 -$200,000.00 N/A N/A

Encision has lower revenue, but higher earnings than Cardiovascular Systems.

Institutional and Insider Ownership

90.6% of Cardiovascular Systems shares are held by institutional investors. 3.0% of Cardiovascular Systems shares are held by insiders. Comparatively, 38.2% of Encision shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.


Cardiovascular Systems beats Encision on 7 of the 12 factors compared between the two stocks.

Cardiovascular Systems Company Profile

Cardiovascular Systems, Inc., a medical device company, develops, manufactures, and commercializes various devices to treat vascular and coronary diseases in the United States. The company offers peripheral arterial disease products, including Diamondback 360 Peripheral, Predator 360, Stealth 360 Peripheral Orbital Atherectomy System (OAS), Diamondback 360 60cm Peripheral OAS, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral, Diamondback 360 2.00 Peripheral, Diamondback 360 200cm Peripheral, and Diamondback 360 180cm Peripheral, which are catheter-based platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives. It also provides Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.

Encision Company Profile

Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. It provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. The company's AEM instruments product line includes a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. It also provides various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; AEM EndoShield 2 burn protection systems; and AEM Burn Protection Cable, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was founded in 1991 and is based in Boulder, Colorado.

Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with's FREE daily email newsletter.